VERA vs IMNM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
VERA · Vera Therapeutics$29.79 ▼ 1.18%
IMNM · Immunome$18.71 ▲ 4.50%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- VERA +7.3%
- IMNM +13.8%
Head to head
| Metric | VERA | IMNM |
|---|---|---|
| Price | $29.79 | $18.71 |
| Change today | ▼ 1.18% | ▲ 4.50% |
| Market cap | $2.15B | $2.21B |
| Return, 3 months | -5.7% | -27.2% |
| Return, year to date | -41.2% | -12.9% |
| Return, 1 year | +23.1% | +22.8% |
| P/E (TTM) | -5.0 | -7.4 |
| P/B | 6.5 | 4.2 |
| P/E percentile vs own 5y | 72nd | 20th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -100.0% |
| Net profit growth (YoY) | -43.0% | -68.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -91.8% | -64.0% |
| Analyst target vs. price | +152.9% | +89.0% |
| Analyst buy share | 91% | 92% |
| RSI (14) | 48 | 46 |
| 30-day volatility | 56.6% | 63.9% |
| Max drawdown, 1 year | -52.0% | -44.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IMNM is the largest of the group by market value.
- VERA has returned the most over the past year.
- IMNM carries the lowest trailing P/E.
- VERA has been the calmest stock over the last 30 days.